Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies (Q39108492)

9 September 2017

Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies (English)

1 reference

9 September 2017

0 references

5

Edward T Ryan

1 reference

9 September 2017

4

Stephen B Calderwood

1 reference

9 September 2017

1

Manohar John

1 reference

9 September 2017

Emily A Bridges

2

1 reference

PubMed ID

12034098

9 September 2017

Andy O Miller

series ordinal

3

1 reference

PubMed ID

12034098

9 September 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

9 September 2017

1 reference

9 September 2017

20

1 reference

9 September 2017

21-22

1 reference

9 September 2017

2720-2726

1 reference

Transcutaneous immunization: a human vaccine delivery strategy using a patch

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Skin immunization made possible by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Induction of systemic immune responses in sheep by topical application of cholera toxin to skin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Transcutaneous immunization of domestic animals: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Transcutaneous immunization: T cell responses and boosting of existing immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Duration of infection-derived immunity to cholera

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Heterologous antigen expression in Vibrio cholerae vector strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Expression of Shigella sonnei lipopolysaccharide in Vibrio cholerae.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Development of a germfree mouse model of Vibrio cholerae infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

Development of a live, oral, attenuated vaccine against El Tor cholera

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900208-6

7 January 2021

10.1016/S0264-410X(02)00208-6

Identifiers

DOI

1 reference

9 September 2017

1 reference

PubMed ID

12034098